Response to Stress in Early Tumor Colonization Modulates Switching of CD133-Positive and CD133-Negative Subpopulations in a Human Metastatic Colon Cancer Cell Line, SW620

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Hsu, Chih Sin ^a   Tung, Chien Yi ^a   Yang, Chih Yung ^a,c   Lin, Chi Hung ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b VGH Yang Ming Genome Research Center   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENICITY; CELL ADHESION; CELL GROWTH; CELL HYPOXIA; CELL PROLIFERATION; CELL SUBPOPULATION; CELL VIABILITY; CELLULAR STRESS RESPONSE; COLON CANCER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; PEPTIDES; STRESS, PHYSIOLOGICAL; TIME FACTORS; TUMOR MICROENVIRONMENT;

EID: 84875966755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061133     Document Type: Article

References (43)

1. Davies JM, Goldberg RM, (2011) Treatment of metastatic colorectal cancer. Semin Oncol 38: 552-560.
2. Sanoff HK, Sargent DJ, Campbell ME, Morton RF, Fuchs CS, et al. (2008) Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol 26: 5721-5727.
3. Shibue T, Weinberg RA, (2011) Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol 21: 99-106.
4. Sampieri K, Fodde R, (2012) Cancer stem cells and metastasis. Semin Cancer Biol 22: 187-193.
5. Soltanian S, Matin MM, (2011) Cancer stem cells and cancer therapy. Tumour Biol 32: 425-440.
6. Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, et al. (2012) Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481: 85-89.
7. Vaiopoulos AG, Kostakis ID, Koutsilieris M, Papavassiliou AG, (2012) Colorectal cancer stem cells. Stem Cells 30: 363-371.
8. Pang R, Law WL, Chu AC, Poon JT, Lam CS, et al. (2010) A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6: 603-615.
9. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, et al. (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021.
10. Wang Q, Chen ZG, Du CZ, Wang HW, Yan L, et al. (2009) Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer. Histopathology 55: 284-293.
11. Li CY, Li BX, Liang Y, Peng RQ, Ding Y, et al. (2009) Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med 7: 56.
12. Horst D, Kriegl L, Engel J, Kirchner T, Jung A, (2008) CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 99: 1285-1289.
13. Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, et al. (2009) The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 219: 427-434.
14. Puglisi MA, Sgambato A, Saulnier N, Rafanelli F, Barba M, et al. (2009) Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer. Eur Rev Med Pharmacol Sci 13 Suppl 1: 55-62.
15. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
16. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105: 13427-13432.
17. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
18. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, et al. (2008) CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15: 2927-2933.
19. Wu Y, Wu PY, (2009) CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 18: 1127-1134.
20. Hongo K, Tanaka J, Tsuno NH, Kawai K, Nishikawa T, et al. (2011) CD133(-) Cells, Derived From a Single Human Colon Cancer Cell Line, Are More Resistant to 5-Fluorouracil (FU) Than CD133(+) Cells, Dependent on the beta1-Integrin Signaling. J Surg Res.
21. Navarro-Alvarez N, Kondo E, Kawamoto H, Hassan W, Yuasa T, et al. (2010) Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties. Cell Transplant 19: 865-877.
22. Dittfeld C, Dietrich A, Peickert S, Hering S, Baumann M, et al. (2009) CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116. Radiother Oncol 92: 353-361.
23. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120.
24. Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L, et al. (2010) The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 70: 719-729.
25. Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, et al. (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36: 4562-4569.
26. Chiang AC, Massague J, (2008) Molecular basis of metastasis. N Engl J Med 359: 2814-2823.
27. Kleinman HK, Martin GR, (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15: 378-386.
28. Harma V, Virtanen J, Makela R, Happonen A, Mpindi JP, et al. (2010) A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 5: e10431.
29. Benton G, George J, Kleinman HK, Arnaoutova IP, (2009) Advancing science and technology via 3D culture on basement membrane matrix. J Cell Physiol 221: 18-25.
30. Lee GY, Kenny PA, Lee EH, Bissell MJ, (2007) Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4: 359-365.
31. Iida H, Suzuki M, Goitsuka R, Ueno H, (2012) Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Int J Oncol 40: 71-79.
32. Yang ZL, Zheng Q, Yan J, Pan Y, Wang ZG, (2011) Upregulated CD133 expression in tumorigenesis of colon cancer cells. World J Gastroenterol 17: 932-937.
33. Pirozzi G, Tirino V, Camerlingo R, Franco R, La Rocca A, et al. (2011) Epithelial to mesenchymal transition by TGFbeta-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS One 6: e21548.
34. Wang J, Sakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, et al. (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122: 761-768.
35. Vermeulen L, de Sousa e Melo F, Richel DJ, Medema JP, (2012) The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol 13: e83-89.
36. You H, Ding W, Rountree CB, (2010) Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. Hepatology 51: 1635-1644.
37. Sun Y, Kong W, Falk A, Hu J, Zhou L, et al. (2009) CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One 4: e5498.
38. Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, et al. (2008) Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res 18: 1037-1046.
39. Feng HL, Liu YQ, Yang LJ, Bian XC, Yang ZL, et al. (2010) Expression of CD133 correlates with differentiation of human colon cancer cells. Cancer Biol Ther 9.
40. Kolenda J, Jensen SS, Aaberg-Jessen C, Christensen K, Andersen C, et al. (2011) Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J Neurooncol 103: 43-58.
41. Hashimoto O, Shimizu K, Semba S, Chiba S, Ku Y, et al. (2011) Hypoxia Induces Tumor Aggressiveness and the Expansion of CD133-Positive Cells in a Hypoxia-Inducible Factor-1alpha-Dependent Manner in Pancreatic Cancer Cells. Pathobiology 78: 181-192.
42. Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, et al. (2011) Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 29: 1547-1555.
43. Elsaba TM, Martinez-Pomares L, Robins AR, Crook S, Seth R, et al. (2010) The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLoS One 5: e10714.